Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2003
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351942A1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1448168A Medicine for kidney reinforcing and beauty treatment
10/15/2003CN1448141A Medine using cornin as main composition for curing chronic nephritis and productive technology thereof
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082798A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082359A1 Tissue treatment
10/09/2003WO2003082338A1 Remedies for glomerular diseases
10/09/2003WO2003082324A1 Prevention and treatment of mycoplasma-associated diseases
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082320A1 Novel screening method
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003024465A3 Use of extracts of the genus cimicifuga as organoselective medicines
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191176 Stable hydrate of a muscarinic receptor antagonist
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191172 Method of using cyclooxygenase inhibitors and antimuscarinic agents
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191135 Serotonergic agents with long-acting in vivo effects
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191099 Antiestrogen compound
10/09/2003US20030191097 Hormone replacement therapy
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190376 Anti-Aromatase composition
10/09/2003US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480630A1 Tissue treatment
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2478017A1 Therapeutic agent for glomerular disease
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 562